Living With The Enemy: Never Letting Our Guard Down
Tags: THERAPEUTICS; AIDS (Disease) -- Treatment; HIV (Viruses) -- Treatment
Related Articles
- CHASING THE CURE. Groopman, Jerome // New Republic;8/12/96, Vol. 215 Issue 7, p14
Discusses the possible factors that may amount to a cure of AIDS as presented at the AIDS Conference in Vancouver, British Columbia in August 1996. Drugs that slow the rate at which the human immune deficiency virus replicates; Factors that could improve the health of AIDS patients; Areas of...
- CNE/CME questions. // AIDS Alert;Feb2009, Vol. 24 Issue 2, p23
A quiz concerning the treatment for HIV and AIDS is presented.
- CNE/CME QUESTIONS. // AIDS Alert;May2010, Vol. 25 Issue 5, p59
A quiz is presented related to medical care for human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) patients.
- HIV Digest. // Guide;Apr2003, Vol. 23 Issue 4, p85
Presents developments in AIDS/HIV treatment as of April 2003. Effect of TNX-355 in HIV levels of patients; Increased risk for heart attacks with antiviral medicines taken by HIV patients; Role of harmless virus GBV-C in slowing the progress of HIV and prolong survival of AIDS patients; Results...
- AN HIV CURE? Smith, Tammie // Essence (Essence);Oct2001, Vol. 32 Issue 6, p80
Presents information on several treatment for HIV and AIDS. Advantages and disadvantages of Post Exposure Prophylaxis therapy; Clinical trials on several HIV drugs and a possible human vaccine; Community outreach programs for the care and education of HIV infected people.
- Factors Associated with Poor Immunologic Responses Despite Viral Suppression in Markedly Immunosuppressed Patients. Collazos, Julio; Asensi, V�ctor; Cart�n, Jos� Antonio // AIDS Patient Care & STDs;Jun2007, Vol. 21 Issue 6, p378
To determine the factors associated with poor immunologic responses despite viral suppression in markedly immunocompromised patients (=200 CD4 cells per microliter at baseline), individuals with less than 100 CD4 increases after 12 months of nelfinavir-based highly active antiretroviral therapy...
- Antiretroviral Therapy as HIV Prevention: Status and Prospects. Mayer, Kenneth H.; Venkatesh, Kartik K. // American Journal of Public Health;Oct2010, Vol. 100 Issue 10, p1867
As antiretroviral treatment of HIV infection has become increasingly accessible, attention has focused on whether these drugs can used for prevention because of increased tolerability of newer medications, decreased cost, and the limitations of other approaches. We review the status of...
- AIDS HOPE. Groopman, Jerome // New Republic;4/3/95, Vol. 212 Issue 14, p18
Calls for additional U.S. federal research funding and spending for HIV and AIDS treatment. Significance of the advances in molecular technology to AIDS treatment research; Manner in which HIV destroys the immune system; Progress in AIDS treatment research as of 1995.
- Universal antiretroviral treatment: the challenge of human resources. B�rnighausen, Till; Bloom, David E.; Humair, Salal // Bulletin of the World Health Organization;Dec2010, Vol. 88 Issue 12, p951
The authors opine regarding universal antiretroviral treatment (ART) for the AIDS virus and the challenges of doing so associated human resource needs. Reference is made to a 2009 report on the subject by the World Health Organization. The article discusses possible explanations of how past...
